Nalaganje...
Remdesivir in COVID-19: A critical review of pharmacology, pre-clinical and clinical studies
BACKGROUND & AIMS: Remdesivir is a broad spectrum anti-viral drug that has shown to inhibit SARS-CoV-2, in vitro and in vivo. In absence of any effective treatment for SARS-CoV-2 infection (COVID-19), remdesivir has been tried for a compassionate use in severe COVID-19. Newer randomized controll...
Shranjeno v:
| izdano v: | Diabetes Metab Syndr |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Diabetes India. Published by Elsevier Ltd.
2020
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7214279/ https://ncbi.nlm.nih.gov/pubmed/32428865 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.dsx.2020.05.018 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|